arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

AVANOS MEDICAL, INC.

AVNS
$24.99 0.00 (0.00%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
15 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

AVANOS MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.2B
Dividend Yield
Revenue Growth 1.9%
Op. Margin -8.8%
ROIC -7.8%
FCF / Share $1.61
Trailing P/E
Price / Book 1.5x
FCF Yield 6.5%
Debt / Equity 0.12
info Valuation on last close. End-of-day price, Jul 24, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$701.20M
↑ +1.9%
Net Income Profit after all expenses
$-72.90M
↑ +81.4%
Operating Margin Operating profit as % of sales
-8.8%
↑ +84.7% 16th
FCF / Share Free cash flow per share
$1.61
↓ -26.3%
Long-Term Debt Long-term obligations
$90.30M
↓ -27.9%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
32
Returns
35
Financial Health
56
Cash Quality
10

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 54 quarters